section name header

Indications

REMS

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: chest pain, DEEP VEIN THROMBOSIS, edema, hypertension.

Derm: ↑ sweating, alopecia, hot flush, pruritus, rash.

F and E: hypercalcemia.

GI: nausea, abdominal pain, anorexia, constipation, diarrhea, dyspepsia, vomiting.

GU: ↓ fertility.

Metab: hypercholesterolemia, weight gain.

MS: musculoskeletal pain, ↓ bone density, arthralgia, fracture.

Neuro: anxiety, depression, dizziness, drowsiness, fatigue, headache, STROKE/TIA, vertigo, weakness.

Resp: cough, dyspnea, pleural effusion, PULMONARY EMBOLISM.

Interactions

Drug-Drug:

Availability

(Generic available)

Route/Dosage

Hepatic Impairment

US Brand Names

Femara

Action

Therapeutic Effects:

Classifications

Therapeutic Classification: antineoplastics

Pharmacologic Classification: aromatase inhibitors

Pharmacokinetics

Absorption: Rapidly and completely absorbed.

Distribution: Well distributed to tissues.

Metabolism/Excretion: Mostly metabolized by the liver. Primarily excreted in the urine (90%), with 6% being excreted as unchanged drug.

Half-life: 2 days.

Time/Action Profile

(effect on lowering of serum estradiol concentrations)

ROUTEONSETPEAKDURATION
POunknown2–3 daysunknown

Patient/Family Teaching

Pronunciation

LET-roe-zole audio

Code

NDC Code*